- Home
- DERM vs EP Comparison
DERM vs EP Comparison
Compare DERM & EP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- EP
- Stock Information
- Founded
- DERM 2014
- EP 1983
- Country
- DERM United States
- EP United States
- Employees
- DERM N/A
- EP N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- EP Oil & Gas Production
- Sector
- DERM Health Care
- EP Energy
- Exchange
- DERM Nasdaq
- EP Nasdaq
- Market Cap
- DERM 165.6M
- EP 167.8M
- IPO Year
- DERM 2021
- EP N/A
- Fundamental
- Price
- DERM $7.23
- EP $4.52
- Analyst Decision
- DERM Strong Buy
- EP
- Analyst Count
- DERM 2
- EP 0
- Target Price
- DERM $10.50
- EP N/A
- AVG Volume (30 Days)
- DERM 108.1K
- EP 23.1K
- Earning Date
- DERM 08-12-2025
- EP 08-13-2025
- Dividend Yield
- DERM N/A
- EP N/A
- EPS Growth
- DERM N/A
- EP N/A
- EPS
- DERM N/A
- EP N/A
- Revenue
- DERM $56,243,000.00
- EP $42,796,178.00
- Revenue This Year
- DERM $28.99
- EP N/A
- Revenue Next Year
- DERM $52.61
- EP N/A
- P/E Ratio
- DERM N/A
- EP N/A
- Revenue Growth
- DERM N/A
- EP 6.28
- 52 Week Low
- DERM $3.54
- EP $3.76
- 52 Week High
- DERM $8.25
- EP $8.12
- Technical
- Relative Strength Index (RSI)
- DERM 49.52
- EP 37.18
- Support Level
- DERM $6.90
- EP $4.40
- Resistance Level
- DERM $8.09
- EP $5.25
- Average True Range (ATR)
- DERM 0.36
- EP 0.33
- MACD
- DERM -0.04
- EP -0.07
- Stochastic Oscillator
- DERM 27.78
- EP 5.15
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About EP Empire Petroleum Corporation
Empire Petroleum Corp is a conventional oil and natural gas producer with a main focus in the United States onshore. The company possesses long-life, mature, producing assets with slow decline profiles in the Permian Basin, Bakken region and central Gulf Coast region, in the states of New Mexico, North Dakota, Montana, Louisiana and Texas. It has production from operated and non-operated wells in Lea County in New Mexico, Bottineau, Renville, Burke, and McKenzie Counties in North Dakota, Richland County in Montana, St. Landry, Beauregard Parishes in Louisiana and Houston, Leon and Madison Counties in Texas.